M&A Deal Summary

Iktos Acquires Synsight

On July 8, 2024, Iktos acquired life science company Synsight

Acquisition Highlights
  • This is Iktos’ 1st transaction in the Life Science sector.
  • This is Iktos’ 1st transaction in France.

M&A Deal Summary
Date 2024-07-08
Target Synsight
Sector Life Science
Buyer(s) Iktos
Deal Type Add-on Acquisition

Target

Synsight

Évry, France
Synsight is a biotech company applying AI and high-content cell imaging to discover novel drug candidates. Synsight was formed in 2013 and is based in Évry, France.

Search 197,704 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Iktos

Paris, France
Category Company
Founded 2016
Sector Life Science
DESCRIPTION

Iktos specializing in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative generative AI solution which enables the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. Iktos was formed in 2016 and is based in Paris, France.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (France) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal